Galectin-1

Galectin-1

Galectin-1 Overview

Molecule Name
Galectin-1
Synonyms
LGALS1,GAL1,GBP,Galectin-1,DKFZp686E23103
Drug Development Progress
Drugs in Clinical Trials1
Approved Drugs1
Highest Development StageApproved
Target Synonym
Epididymis Secretory Sperm Binding Protein,Lectin, Galactoside-Binding, Soluble, 1,Beta-Galactoside-Binding Lectin L-14-I,14 KDa Laminin-Binding Protein,S-Lac Lectin 1,14 KDa Lectin,Galaptin,HLBP14,Gal-1,HPL,Beta-Galactoside-Binding Protein 14kDa,Lectin Galactoside-Binding Soluble 1,GAL1,GBP,Galectin 1,Putative MAPK-activating protein PM12,Galectin-1,HBL,LGALS1,Lactose-binding lectin 1
Background
Galectin-1 (Gal-1), a member of the β-galactoside-binding animal lectin family, has a wide range of biological activities, which makes it an attractive target for medical applications. Gal-1 is ubiquitously but differentially expressed in normal and pathological animal tissues, and a variety of biological activities, including modulation of innate and adaptive immune responses, malignant progression of tumor cells, etc.

Galectin-1 Product List

Species
  • Human(1)
Tag
  • Tag Free(1)
Host
  • E. coli(1)
Conjugate
  • Unconjugated(1)
Grade
  • RUO(1)
Low Endotoxin
  • Yes(1)
MoleculeCat. No.Product NameSpeciesHostStructurePurityActivitySize&PriceAdd to Cart
Galectin-1
Human Galectin-1 / LGALS1 Protein, Tag Free, low endotoxin (MALS & BLI verified)
Human
E. coli
MALSSDS-PAGE
SPRBLI

$340.00

100ug
You Have Viewed 1-1 Of 1 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Asset Licensing Opportunity
Resources

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
OlitigaltinGB-0139; TD-139Phase 2 ClinicalLund University Foundation, The University Of Edinburgh
Coronavirus Disease 2019 (COVID-19); Idiopathic Pulmonary Fibrosis
Details

Marketed Drug Information

English NameResearch CodeHighest Development StageCompanyFirst Brand NameFirst Approved CountryFirst IndicationFirst Approved CompanyFirst Approved DateIndicationClinical Trial
OcriplasminA-01016; THR-409ApprovedThrombogenicsJetrea, JejetreaUnited StatesVitreomacular AdhesionThrombogenics Inc2012-10-17
Arterial Occlusive Diseases; Diabetic macular oedema; Diabetic Retinopathy; Disease Progression; Eye Diseases; Macular Degeneration; Retinal Diseases; Retinal Vein Occlusion; Stroke; Uveitis; Venous Thrombosis; Vitreomacular Adhesion; Vitreous Detachment
Details
Customer Reviews
  • L***h2021-12-13
    Dear Sir or Madam, I had an overall good service from Acro Biosystems. Shipment was fast and product quality was good. Got the protocol for QC after asking the customer service. Protocol for QC was easy to understand and repeat. Easy way to download the Certificate of Analysis via the printed QR code on product vials. Customer service answered very fast and was very friendly. QC of Human Galectin-1 protein vs. biotinylated human CD45 protein (CD5-H82E7) was fine.